[go: up one dir, main page]

WO2005026369A3 - Vecteurs d’expression d’arn interferents, leurs procedes de preparation et leurs utilisations. - Google Patents

Vecteurs d’expression d’arn interferents, leurs procedes de preparation et leurs utilisations. Download PDF

Info

Publication number
WO2005026369A3
WO2005026369A3 PCT/FR2004/002267 FR2004002267W WO2005026369A3 WO 2005026369 A3 WO2005026369 A3 WO 2005026369A3 FR 2004002267 W FR2004002267 W FR 2004002267W WO 2005026369 A3 WO2005026369 A3 WO 2005026369A3
Authority
WO
WIPO (PCT)
Prior art keywords
interference rna
rna expression
production
methods
expression vectors
Prior art date
Application number
PCT/FR2004/002267
Other languages
English (en)
Other versions
WO2005026369A2 (fr
Inventor
Pascale Nony
Sophie Chappuis
Original Assignee
Transat
Pascale Nony
Sophie Chappuis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transat, Pascale Nony, Sophie Chappuis filed Critical Transat
Publication of WO2005026369A2 publication Critical patent/WO2005026369A2/fr
Publication of WO2005026369A3 publication Critical patent/WO2005026369A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention se rapporte à un vecteur d'expression d'ARN interférent caractérisé en ce qu'il comprend un ou plusieurs éléments isolants protégeant les molécules d'ADN codant pour l'ARN interférent contre les séquences régulatrices des cellules.
PCT/FR2004/002267 2003-09-08 2004-09-07 Vecteurs d’expression d’arn interferents, leurs procedes de preparation et leurs utilisations. WO2005026369A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0310565A FR2859482B1 (fr) 2003-09-08 2003-09-08 Vecteurs d'expression d'arn interferents, leurs procedes de preparation et leurs utilisations
FR0310565 2003-09-08

Publications (2)

Publication Number Publication Date
WO2005026369A2 WO2005026369A2 (fr) 2005-03-24
WO2005026369A3 true WO2005026369A3 (fr) 2005-06-09

Family

ID=34178841

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/002267 WO2005026369A2 (fr) 2003-09-08 2004-09-07 Vecteurs d’expression d’arn interferents, leurs procedes de preparation et leurs utilisations.

Country Status (2)

Country Link
FR (1) FR2859482B1 (fr)
WO (1) WO2005026369A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610053A (en) * 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AN D.S. ET AL.: "Efficient lentiviral vectors for short hairpin RNA delivery into human cells.", HUMAN GENE THERAPY, vol. 14, 10 August 2003 (2003-08-10), pages 1207 - 1212, XP002277891 *
RECILLAS-TARGA F ET AL: "Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 99, no. 10, 14 May 2002 (2002-05-14), pages 6883 - 6888, XP002274806, ISSN: 0027-8424 *
YANNAKI E., TUBB J., AKER M., STAMATOYANNOPOULOS G. & EMERY D.W.: "Topological constraints governing the use of chicken HS4 chromatin insulator in oncoretrogenic vecors.", MOLECULAR THERAPY, vol. 5, no. 5, May 2002 (2002-05-01), pages 589 - 598, XP002316215 *

Also Published As

Publication number Publication date
WO2005026369A2 (fr) 2005-03-24
FR2859482B1 (fr) 2005-11-11
FR2859482A1 (fr) 2005-03-11

Similar Documents

Publication Publication Date Title
WO2003080807A8 (fr) Compositions et methodes destinees a supprimer l'expression de genes eucaryotes
WO2007058527A3 (fr) Systemes d’expression inductible
WO2003093441A3 (fr) Procede de regulation de l'expression genique
WO2005074647A3 (fr) Polypeptides presentant une activite favorisant l'activite cellulolytique, et polynucleotides codant lesdits polypeptides
WO2003016475A3 (fr) Sequences d'acides nucleiques et d'acides amines intervenant dans la douleur
WO2006046148A3 (fr) Constructions d'arn
WO2005048957A3 (fr) Nouveaux sites d'insertion dans des vecteurs de variole
WO2006078256A3 (fr) Polypeptides presentant une activite xylanase et polynucleotides codant pour ceux-ci
EP1889907A4 (fr) Nouvelle transférase de groupe aminé, gène codant celle-ci et procédé d'utilisation de celle-ci
WO2006047469A3 (fr) Polypeptides a activite lipase et polynucleotides les codant
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO2005065339A3 (fr) Genes de cycles cellulaires et leurs procedes d'utilisation associes
WO2006076628A3 (fr) Compositions renfermant des sequences promoteurs et procedes d'utilisation
WO2005103279A3 (fr) Genes de synthese
WO2002004677A8 (fr) Procede destine au diagnostic et au traitement de troubles mentaux
WO2005087932A3 (fr) Vecteurs pour le clonage directionnel
WO2002102984A3 (fr) Polypeptides d'hdac9, polynucleotides et leurs utilisations
ATE532861T1 (de) Expressionsvektor
WO2005049806A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2006097110A3 (fr) Polypeptides a activite antimicrobienne et polynucleotides codant pour ces polypeptides
WO2003016550A3 (fr) Compositions et procedes comprenant un acide nucleique temoin
TW200621284A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
WO2001059120A3 (fr) Molecules de type il-17 et utilisation de ces dernieres
WO2006005032A3 (fr) Polypeptides ayant l'activite d'alpha-glucosidase et polynucleotides les codant
WO2005026369A3 (fr) Vecteurs d’expression d’arn interferents, leurs procedes de preparation et leurs utilisations.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MK MN MW MX MZ NA NI NO NZ PG PH PL PT RO RU SC SD SE SG SK SY TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IT MC NL PL PT RO SE SI SK TR BF CF CG CI CM GA GN GQ GW ML MR SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase